Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Shares withheld for taxes President and CCO gave up 8,181 shares (to pay taxes)
  2. 4 Planned sale Chief Legal Officer sold 21,210 shares at $7.65 ($162,257)
  3. 4 Shares withheld for taxes Chief Executive Officer gave up 27,368 shares (to pay taxes)
  4. 4 Planned sale Chief Legal Officer sold 161,680 shares at an average $7.21 ($1,164,967)
  5. 4 Grant or award Director acquired 783 shares (grant or award)
  6. 4 Grant or award Director acquired 1,566 shares (grant or award)
  7. 4 Grant or award Director acquired 783 shares (grant or award)
  8. 4 Planned sale Director sold 9,600 shares at $7.14 ($68,544)
  9. 4 Grant or award Director acquired 676 shares (grant or award)
  10. 4 Grant or award Director acquired 1,353 shares (grant or award)
  11. 4 Grant or award Director acquired 676 shares (grant or award)
  12. 4 Open-market sale Director sold 70,000 shares at $8.51 ($595,868)
  13. 4 Grant or award CFO & Head of Corp Development acquired 147,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Director acquired 12,500 shares (grant or award)
  16. 4 Grant or award Director acquired 12,500 shares (grant or award)
  17. 4 Grant or award Director acquired 12,500 shares (grant or award)
  18. 4 Grant or award Director acquired 12,500 shares (grant or award)
  19. 4 Grant or award Director acquired 12,500 shares (grant or award)
  20. 4 Grant or award Director acquired 12,500 shares (grant or award)

Page 3 of 49 · 965 filings